Selective internal radiation therapy with Yttrium-90 for unresectable liver tumours

Reviews on Recent Clinical Trials

Volumn 2, Issue 3, 2007, Pages 212-216

  Khodjibekova, Malika ^a,b   Szyszko, Teresa ^a   Khan, Sameer ^a   Nijran, Kuldip ^a   Tait, Paul ^a   Al Nahhas, Adil ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Department of Nuclear Medicine   (Uzbekistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CORTICOSTEROID; FLOXURIDINE DERIVATIVE; FLOXURIDINE Y 90; FLUORODEOXYGLUCOSE F 18; MACROSALB TC 99M; MICROSPHERE; STEROID; UNCLASSIFIED DRUG; YTTRIUM 90;

ABDOMINAL PAIN; ARTICLE; ASCITES; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHOLECYSTITIS; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIGESTIVE SYSTEM ULCER; DOSIMETRY; DRUG FEVER; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; GALLBLADDER DISEASE; GASTRITIS; HEPATITIS; HEPATOMEGALY; HUMAN; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; MULTIPLE CYCLE TREATMENT; PORTAL HYPERTENSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION PNEUMONIA; RADIATION SICKNESS; RADIOFREQUENCY ABLATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; VOMITING;

BRACHYTHERAPY; FLUORODEOXYGLUCOSE F18; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MICROSPHERES; PALLIATIVE CARE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; YTTRIUM RADIOISOTOPES;

EID: 35048893751     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488707781662742     Document Type: Article

References (55)

1. Lau WY, Ho S, Leung WT. Multi-Treatment Modalities of Liver Tumours, Edited by Nagy Habib. Kluwer Academic/Plenum Publishers, New York, 2002; 323-44.
2. Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 1994; 35: 1637-44.
3. Coldwell D, Nutting C, Kennedy AK. Treatment of hepatic metastases from breast cancer with yttrium-90 SIR-Sphers radioembolization. Presented at the Society of Interventional Radiology Annual Meeting; March 31 through April 5, 2005; New Orleans, LA.
4. Coldwell D, Nutting C, Kennedy AK. Use of yttrium-90 Sir Spheres to treat metastatic unresectable neuroendo tumors to the liver. Presented at the World Congress of Gastrointestinal Cancer; June 27-30, 2005; Barcelona, Spain.
5. Coldwell D, Nutting C, Kennedy AS. Initial clinical results in the treatment of unresectable hepatic tumors with resin-based yttrium-90 radioembolization. Presented at the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Annual Meeting; September 25-29, 2004; Barcelona, Spain.
6. Herba MJ, Illescas FF, Thirlwell MP, et al. Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology 1988; 169: 311-4.
7. Kennedy A, Coldwell D, Nutting C, et al. Hepatic brachytherapy for GI neuroendocrine tumors with Y90 microspheres: long-term USA results. Presented at International Congress on Anti-cancer Treatment; February 1-4, 2005; Paris.
8. Kulik L, Atassi B, van Holsbeeck L, et al. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RF ablation and bridge to transplantation. J Surg Oncol 2006; 94: 572-86.
9. Kulik LM, Mulcahy NO, Hunter RD, et al. Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report. Liver Transpl 2005; 11: 1127-1131 http://www.jvir.org/cgi/ external_ref?access_num=16123954&link_type=MED.
10. Lau WY, Ho SK, Yu SC, et al. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 2004; 240: 299-305.
11. Lewandowski R, Salem R, Thurston K, et al. Radiation segmentectomy of unresectable of liver carcinoma using selective infusion of intraarterial yttrium-90 TheraSphere. Presented at the Radiological Society of North America; November 28-December 3, 2004; Chicago, IL.
12. Rhee TK, Omary RA, Gates V, et al. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol 2005; 16: 1085-91.
13. Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005; 16: 1627-39.
14. Cha C, DeMatteo RP, Blumgart LH. Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol 2002; 35 (5 Suppl 2): S130-7.
15. D'Angelica M, Fong Y. The liver. In: Townsend C, Beauchamp RD, Evers BM, Mattox KL, editors. Sabiston textbook of surgery: the biological basis of modern surgical practice. Philadelphia: Elsevier Saunders; 2004. p. 1513-73.
16. Fong Y, Sun RL, Jamagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 1999; 229(6): 790-800.
17. Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transplant 2004; 10(2 Suppl 1): S107-10.
18. Salem R, Lewandowski R, Roberts C, et al. Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 2004; 15(4): 335-45.
19. Ho S, Lau WY, Leung TW, et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 1997; 24: 293-8.
20. Nutting CKA, Coldwell D, Jones B, et al. Coil embolization prevents GI ulcers during Yttrium-90 Hepatic radioembolization. J Vasc Interv Radiol 2004; 15(2): suppl.
21. Yip D, Allen R, Ashton C, et al. Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 2004; 19: 347-9.
22. Sato KT, Omary RA, Ryu R, et al. Radioembolization with yttrium-90 microspheres: angiographic and technical considerations. Tech Vasc Interv Radiol 2006.
23. Murthy R, Nunez R, Szklaruk J, et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations and potential complications. Radiographics 2005; 25: S41-S55.
24. Liu DM, Salem R, Bui JT, et al. Angiographic considerations in patients undergoing liver directed therapy. J Vasc Interv Radiol 2005; 16: 911-35.
25. SIR-Spheres Yttrium-90 microspheres [package insert]. Lane Cove, Australia: SIRTeX Medical, 2004.
26. Sirtex Medical Training Manual. Lane Cove, Australia: SIRTeX Medical, 2005.
27. Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 2005; 16(2 Pt1): 205-13.
28. Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002; 53(4): 810-21.
29. Yorke ED, Jackson A, Fox RA, et al. Can current models explain the lack of liver complications in Y-90 microsphere therapy? Clin Cancer Res 1999; 5(10 suppl): 3024s-30s.
30. Cheng JC, Wu JK, Huang CM, et al. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. Radiother Oncol 2002; 63: 41-5.
31. 90Y microspheres. Nucl Med Commun 2007; 28, 1: 21-4.
32. Houle S, Yip TK, Shepherd FA, et al. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology 1989; 172: 857-60.
33. Shepherd FA, Rotstein LE, Houle S, et al. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 1992; 70: 2250-4.
34. Lau WY, Ho S, Leung TW, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intrarterial infusion of 90Yttrium microspheres. Int J Radiation Oncol Biol Phys 1998; 40: 583-92.
35. Dancey JE, Shepherd FA, Paul K, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 2000; 41(10): 1673-81.
36. Gershwind JK, Salem R, Carr BI. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004: 127(5 suppl 1): S194-205.
37. Liu M, Uaje M, Al-ghazi MS, et al. Use of yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg 2004; 70(11): 947-53.
38. Pompili M, Mirante VG, Rondinara G, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 2005; 11: 1117-26.
39. Wong LL, Tanaka K, Lau L, et al. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clin Transplant 2004; 18: 227-34.
40. Gray BN, Burton MA, Kelleher DK, Anderson J, Klemp P. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol 1989; 42(3): 192-6.
41. Gray BN, Anderson JE, Burton MA, et al. Regression of liver metastases following treatment with yttrium-90 microspheres Aust N Z J Surg 1992; 62:105-10.
42. Gray BN, Van Hazel G, Buck M, Paton G, Burton M, Anderson J. Treatment of colorectal liver metastases with SIR-Spheres plus chemotherapy. Gastrointestinal Cancer 2000; 3(4): 249-57.
43. Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR Spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001; 12: 1711-20.
44. Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy vs fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004; 88: 78-85.
45. Murthy R, Xiong H, Nunez R, et al. Yttrium90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 2005; 16: 987-45.
46. Stubbs R, Cannan RJ, Mitchell A. Selective internal radiation therapy with 90 Yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 2001; 5(3): 294-302.
47. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 2001; 48: 333-7.
48. Stubbs RS, Wickremesekera SK, Boppudi S. Selective internal radiation therapy (SIRT) for the treatment of advanced colorectal liver metastases. J Gastrointest Surg 2003; 7: 262-3.
49. Kennedy A, Coldwell D, Nutting C, Overton C, Sailer S. Liver Brachytherapy for Unresectable Colorectal Metastases: US Results 2000-2004. Abstract No 145. 2005 GI Cancer Symposium 43rd ASCO Annual Meeting.
50. Jiao LR, Szyszko T, Al-Nahhas A, et al. Clinical and Imaging experience with Yttrium-90 microspheres in management of unresectable liver tumours. Eur J Surg Oncol 2007; 33(5): 597-602.
51. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.
52. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
53. Wong CY, Salem R, Qing F, et al. Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET. J Nucl Med 2004; 45: 1892-7.
54. Popperl G, Helmberger T, Munzing W, Schmind R, Jacobs TF, Tasch K. Selective internal radiation therapy with SIR-spheres in patients with nonresectable liver tumours. Cancer Biother Radiopharm 2005; 20: 200-8.
55. Szyszko T, Al-Nahhas A, Canelo R, et al. Assessment of early response to Yttrium-90 microspheres treatment of liver tumours: value of FDG PET vs computed tomography. Nucl Med Commun 2007; 28: 15-20.